Reply to the letter to the editor ‘The ESMO Magnitude of Clinical Benefit Scaling Tool: from theory to practice’ by Hartmann and the letter ‘Comment on ESMO Magnitude of Clinical Benefit Scale’ by Muhonen et al.
Cherny, N. I., Sullivan, R., Dafni, U., Kerst, J. M., Sobrero, A., Zielinski, C., de Vries, E. G. E., Piccart, M. J.Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv502
Date:
October, 2015
File:
PDF, 263 KB
english, 2015
File converter
More search results
More benefits 
